Does Mounjaro Cause Gas and Bloating?

What the trial data actually show about gas and gut symptoms

The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled 2,539 adults with obesity and tracked them across 72 weeks of tirzepatide treatment. Gastrointestinal events were the most frequently reported adverse effects across all dose groups. Nausea, diarrhoea and constipation topped the list numerically, but bloating, flatulence and burping were also documented, and in practice, many people experience some combination of all of them rather than one symptom in isolation.

The NHS tirzepatide medicines page lists flatulence and belching as known side effects, placing them alongside nausea, vomiting, indigestion and reflux as part of the recognised gut-related profile of the drug. Importantly, the trial data also show that the majority of these effects were mild to moderate in severity, and that discontinuation rates due to GI side effects, while non-trivial, were substantially lower than the proportion who experienced them at all, meaning most people tolerated them and continued.

Severity tends to track with dose. People at higher maintenance doses reported more GI events than those at lower doses, which is part of why the prescribing schedule starts low and titrates gradually. The gas and bloating a person notices at 2.5mg is not necessarily what they will experience at 10mg, and vice versa.

The mechanism behind the wind: why Mounjaro slows things down

Mounjaro activates both GIP and GLP-1 receptors, the only licensed weight-loss medicine in the UK to do so. One shared effect of both receptor pathways is a slowing of gastric emptying: food leaves the stomach more gradually, which prolongs the feeling of fullness and reduces overall intake. That is central to how Mounjaro produces weight loss.

The trade-off is that slower gut transit gives gut bacteria more time to ferment undigested carbohydrates and fibre, and that fermentation produces gas. The same mechanism that keeps you feeling full for longer can leave gas sitting in the intestine for longer too. Burping happens higher up the tract when the stomach itself is slow to empty and air becomes trapped; flatulence and bloating come from the lower gut. Both can occur in the same person at the same time.

This is a question our prescribers hear most weeks, people are often surprised that a weight-loss medicine affects the gut in ways that go beyond just feeling less hungry. Understanding the mechanism tends to make the experience feel less alarming and easier to manage practically.

Which foods tend to make it worse, and what can help

Because the root cause is slowed gut motility rather than a food intolerance, there is no single food that categorically causes problems. That said, some categories are reliably associated with more fermentation and more gas production: cruciferous vegetables (broccoli, cabbage, Brussels sprouts), pulses and legumes, carbonated drinks, high-fructose foods, and very large meals eaten quickly. On Mounjaro, the gut's reduced clearing speed amplifies the gas that these foods produce under normal circumstances.

Practical strategies that many people find useful include eating smaller portions more slowly, giving the gut more time between meals, temporarily reducing the highest-gas foods during the early weeks of a new dose, and staying well hydrated to keep gut contents moving. Chewing food thoroughly and avoiding talking while eating both reduce swallowed air, which contributes to belching. You can read more about wind specifically on Mounjaro and what to do about gas on tirzepatide on our dedicated pages.

If symptoms are persistent or severe enough to affect daily life, that is a conversation to have with your prescriber rather than something to manage alone. Dose timing, titration pace and dietary support can all be adjusted within a supervised treatment plan. A broader overview of Mounjaro as a treatment covers other aspects of what to expect.

When gas and bloating are worth reporting, and the wider context

Most gas on Mounjaro is uncomfortable rather than dangerous. The point at which it becomes worth contacting a clinical team is if it is severe, worsening rather than settling, accompanied by significant pain, or combined with other symptoms such as persistent vomiting, signs of dehydration, or severe abdominal pain that radiates to the back. That last combination is the symptom pattern associated with acute pancreatitis (a known but infrequent side effect flagged in a January 2026 MHRA Drug Safety Update for GLP-1 medicines) and it warrants urgent medical assessment rather than a wait-and-see approach.

For the vast majority of people, though, gas during Mounjaro treatment follows a predictable pattern: noticeable at the start or after an increase, gradually settling, and manageable with modest dietary adjustments. The side-effect profile of tirzepatide is broader than gas alone, and a complete picture is worth understanding before starting. You can also explore the full tirzepatide overview for a wider look at what the clinical evidence covers.

If you are weighing up treatment and want a prescriber to assess your specific situation, starting a free consultation with nume puts that conversation with a named clinician, not a chatbot, the same day.